tweenvest

SynBiotic SE (XTRA: SBX)

Health Care · Pharmaceuticals · DE

€0.11

0.00% today · -94.6% 1Y

Public summary
A free snapshot of SynBiotic SE, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

SynBiotic SE (XTRA: SBX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $858.34K and employs 79 people.

Over the last twelve months the share price has lost 94.6%, trading between 0.10 and 3.85.

Tweenvest scores SynBiotic SE across four factors: quality 45/100, value 70/100. Its strongest factor is value.

SBX price history

Nov 21, 2025 · 2.05Weekly closes 0.11 – 3.37Nov 19, 2026 · 0.11

Key figures

Market cap
$858.34K
Revenue (TTM)
$15.38M
P/E
-0.08
EPS
-1.66
Dividend yield
—
Beta (5Y)
0.96
52-week high
€3.85
52-week low
€0.10
Avg volume (3M)
—
Shares outstanding
6.82M
Employees
79
Next earnings
—

About SynBiotic SE

SynBiotic SE is dedicated to pioneering cannabinoid-based pharmaceuticals and readily available health and wellness items. Its primary strategic pillars include the laboratory synthesis of cannabinoids, advanced drug discovery, the formulation of dietary aids, and the creation of cosmetic solutions. Formerly operating as Ledgertech SE, the company is headquartered in Munich, Germany.

ISIN
DE000A3E5A59
Founded
2024
Listed since
Jan 7, 2021
Exchange
XETRA Trading Platform
Currency
EUR
CompanyMarket capPriceDay
Kaya Holdings, Inc.OTCPK: KAYS$892.36K$0.000.00%
Aoxing Pharmaceutical Company, Inc.OTCPK: AOXG$876.78K$0.000.00%
SciSparc Ltd.NasdaqCM: SPRC$869.84K$0.35-0.62%
Rimrock Gold Corp.OTCPK: RMRK$865.21K$0.000.00%
Tikun Olam-Cannbit Pharmaceuticals LtdTASE: TKUN-M$855.47K₪1,619.00+17.75%
RAMM Pharma Corp.CNSX: RAMM$833.03KCA$0.01-33.33%
Nirvana Life Sciences Inc.CNSX: NIRV.X$828.44KCA$0.050.00%
Evofem Biosciences, Inc.OTCPK: EVFM$821.69K$0.01+6.90%

Browse every Pharmaceuticals company →